![Pierre Heimendinger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pierre Heimendinger
Corporate Officer/Principal bij TXCELL
Profiel
Pierre Heimendinger is currently the Vice President-Process Development at Sangamo Therapeutics France SAS.
He holds a doctorate degree from Université Paris Diderot-Paris 7.
Actieve functies van Pierre Heimendinger
Bedrijven | Functie | Begin |
---|---|---|
TXCELL | Corporate Officer/Principal | - |
Opleiding van Pierre Heimendinger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Sangamo Therapeutics France SAS
![]() Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Université Paris Diderot-Paris 7 | Consumer Services |